Cargando…
Comments on “Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial”
Autores principales: | Moran, Jose M., Pedrera-Zamorano, Juan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319180/ https://www.ncbi.nlm.nih.gov/pubmed/28219349 http://dx.doi.org/10.1186/s12906-017-1629-z |
Ejemplares similares
-
Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial
por: Wang, Shuhua, et al.
Publicado: (2016) -
Comment on “Clinical Dementia Rating Orientation Score as an Excellent Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment”
por: Kawada, Tomoyuki
Publicado: (2018) -
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial
por: Salvadori, Emilia, et al.
Publicado: (2021) -
Cognitive Reserve Characteristics and Occupational Performance Implications in People with Mild Cognitive Impairment
por: Mendoza-Holgado, Cristina, et al.
Publicado: (2021) -
Comment on “Assessment of Bone Mineral Density in Male Patients with Chronic Obstructive Pulmonary Disease by DXA and Quantitative Computed Tomography”
por: Moran, Jose M., et al.
Publicado: (2017)